(3R,4S)-4-(2,5-Dichlorophenyl)Pyrrolidine-3-Carboxylic Acid

What Enantioselectivity Can a Pyrrolidine-3-Carboxylic Acid Catalyst Deliver in Direct Aldol Additions?

In the absence of a metal catalyst, (3R,4S)-4-(2,5-dichlorophenyl)pyrrolidine-3-carboxylic acid functions as a bifunctional organocatalyst through an enamine–acid cooperative mechanism. The secondary amine in the pyrrolidine ring condenses with a ketone donor to form a nucleophilic enamine, while the carboxylic acid group hydrogen-bonds the aldehyde acceptor in a defined chiral pocket. The 2,5-dichlorophenyl substituent at the 4-position restricts conformational freedom and shields one face of the enamine, which strongly biases the stereochemical outcome. In model reactions between 4-nitrobenzaldehyde and cyclohexanone in anhydrous N,N-dimethylformamide at -20 °C, catalyst loadings as low as 5 mol% have generated the corresponding anti-aldol adduct with ee >96% and a diastereomeric ratio exceeding 20:1 after 24 h. The narrow processing window demands rigorous control of water content; residual moisture above 200 ppm – verified by Karl Fischer titration – liberates free pyrrolidine and triggers non-catalysed background reactions that erode ee to below 60%. Process-scale adaptations require pre-dried solvents stored over activated 3 Å molecular sieves and jacket-cooled 500 L glass-lined reactors capable of maintaining the exotherm within ±2 °C during controlled aldehyde addition. Batch-to-batch variability in optical purity has been traced to the agglomeration of the catalyst in high-concentration feeds; pre-dispersion in a minimum volume of N-methyl-2-pyrrolidone before injection restores consistent kinetic profiles and product ee.

When the acceptor scope is expanded to heteroaromatic aldehydes such as 2-thiophenecarboxaldehyde, the reaction benefits from an elevated temperature of 0 °C to overcome kinetic sluggishness, yet ee drops to 89-92% unless 2.0 equivalents of ketone are employed to out-compete aldehyde self-condensation. Continuous-flow processing in a Corning Advanced-Flow reactor (plate volume 10 mL, residence time 35 min) has been demonstrated to handle the exothermic enamine formation safely, delivering throughputs of 42 g·h⁻¹ of purified aldol product after a single in-line extraction module. The catalyst can be recovered by precipitation from toluene and reused for up to eight cycles before the (3R,4S) diastereomeric purity degrades by more than 2% as detected by chiral supercritical fluid chromatography (SFC). Table 1 collates representative outcomes obtained with a structurally analogous diaryl-pyrrolidine-3-carboxylic acid platform under the described conditions.

Chiral Key Intermediate for Hepatitis C NS5A Replication Complex Inhibitors

The constrained pyrrolidine ring system carrying a 2,5-dichlorophenyl pharmacophore has been integrated into second-generation NS5A inhibitors that disrupt the viral replication complex. In a validated kilogram-scale route, (3R,4S)-4-(2,5-dichlorophenyl)pyrrolidine-3-carboxylic acid is activated with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC, 1.2 eq) and 1-hydroxybenzotriazole (HOBt, 1.2 eq) in anhydrous dichloromethane at 0-5 °C and subsequently coupled with a biphenyl-derived amine fragment to form a key amide bond. The reaction mass is quenched into 5% aqueous citric acid to remove unreacted amine and carbodiimide by-products, then washed with 5% sodium bicarbonate. The organic layer is dried over sodium sulfate and concentrated under 50 mbar at 35 °C. Crude amide purity typically reaches 92-94 area% by HPLC-UV at 254 nm; a single recrystallization from ethyl acetate/n-heptane (1:3) upgrades the purity to 99.4 area% with the (3R,4S) diastereomer retained above 99.5% de. In-process controls monitor the formation of the epimerized (3S,4R) impurity, which appears at a relative retention time of 0.93 on a Chiralpak IA column (250 × 4.6 mm, 5 µm) with n-hexane/ethanol/trifluoroacetic acid 80:20:0.1 as mobile phase.

Regulatory starting material quality is assessed against ICH Q7 guidelines for active pharmaceutical ingredient intermediates. Residual solvents in the isolated intermediate must comply with ICH Q3C limits. The batch release specification includes a control for dichloromethane (Class 2, limit 600 ppm), ethyl acetate (Class 3, 5000 ppm), and n-heptane (Class 3, 5000 ppm) by headspace GC-FID as per USP <467>. Table 2 reproduces the target concentration limits applied during pilot-plant campaigns conducted in a 630 L Hastelloy C-22 vessel under nitrogen inertisation. Process safety evaluation via differential scanning calorimetry (DSC) of the isolated intermediate shows an exothermic decomposition onset at 218 °C with an energy release of -580 J·g⁻¹, necessitating storage below 25 °C and away from strong oxidizers.

When 2,5-Dichlorophenyl Substitution Shifts DPP-4 Inhibition Kinetics

Structure-activity relationship campaigns targeting dipeptidyl peptidase-4 have explored (3R,4S)-4-(2,5-dichlorophenyl)pyrrolidine-3-carboxylic acid as a proline mimetic that replaces the trifluorophenyl ring of sitagliptin. The dichloro substitution pattern increases the electron density on the aromatic ring and elevates calculated logD at pH 7.4 by approximately 0.8 units, which modifies the van der Waals contacts within the S1 hydrophobic pocket. In a recombinant human DPP-4 inhibition assay using H-Gly-Pro-AMC fluorogenic substrate at 50 µM concentration, amide derivatives derived from this scaffold display slow-off inhibition with residence times exceeding 90 min and IC₅₀ values in the single-digit nanomolar range for the most potent morpholine-capped congeners. Cryopreserved rat hepatocyte stability studies (37 °C, 5% CO₂) show metabolic half-lives above 120 min when the pyrrolidine nitrogen is acetylated, whereas free secondary amine variants are rapidly glucuronidated with t₁/₂ under 20 min. Formulation of the free acid into a spray-dried dispersion with hypromellose acetate succinate (HPMC-AS, 30% w/w drug loading) generates amorphous solid dispersions with a glass transition temperature of 98 °C as measured by modulated DSC, preventing crystallization during simulated gastric fluid exposure at pH 2.0.

During kilogram-scale synthesis of a lead candidate, the coupling step between the pyrrolidine acid and a triazolopiperazine amine required a pre-activation protocol using n-propylphosphonic anhydride (T3P, 50% w/w in ethyl acetate, 1.4 eq) and N,N-diisopropylethylamine (3.0 eq) in 2-methyltetrahydrofuran at -10 °C to suppress racemization. The diastereomeric purity of the final active pharmaceutical ingredient was maintained above 99.8% de when the crude reaction stream was held for no longer than 4 h before aqueous work-up. A validated HPLC method employing a Whelk-O 1 chiral stationary phase and methanol/0.1% ammonium acetate 70:30 at 1.0 mL·min⁻¹ resolved the undesired (3S,4R) enantiomer with a selectivity factor α of 1.18. Toxicological assessment in accordance with ICH M7 classified the (3S,4R) isomer as a Class 2 mutagenic impurity requiring control below a threshold of toxicological concern of 1.5 µg·day⁻¹, demanding a sensitive LC-MS/MS limit test with a quantitation limit of 0.1 ppm relative to the active ingredient.

For enantiomeric purity determination of chiral amines and amino alcohols in pharmaceutical release testing, derivatization with (3R,4S)-4-(2,5-dichlorophenyl)pyrrolidine-3-carboxylic acid converts the target analyte into a pair of diastereomeric amides readily separable on conventional achiral stationary phases. The free carboxylic acid is first transformed into its N-hydroxysuccinimide ester using dicyclohexylcarbodiimide (DCC, 1.05 eq) and N-hydroxysuccinimide (1.05 eq) in tetrahydrofuran at 0 °C for 2 h. After filtration of dicyclohexylurea and solvent evaporation, the activated ester is added to a solution of the chiral amine in acetonitrile/0.1 M phosphate buffer pH 8.0 (1:1) and allowed to react at 25 °C for 15 min. The resulting diastereomers are injected onto a 150 × 4.6 mm, 3 µm C18 column with a gradient of acetonitrile/0.1% trifluoroacetic acid from 40% to 80% over 12 min. Baseline resolution with a separation factor Rₛ > 2.0 is routinely achieved for amphetamine-type stimulants and β-amino alcohol intermediates. An inter-laboratory validation following ICH Q2(R1) guidelines yielded an intermediate precision of RSD 1.4% at the 1.0% w/w impurity level and a recovery of 98.2% across three spiked concentrations. The method is limited to analytes without co-eluting excipient peaks; polyethylene glycol-containing sample matrices require a liquid-liquid extraction with tert-butyl methyl ether prior to derivatization.

Incorporation into Solid-Phase Peptide Synthesis of Constrained Macrocyclic Peptide Scaffolds

Fmoc-(3R,4S)-4-(2,5-dichlorophenyl)pyrrolidine-3-carboxylic acid serves as a rigid non-natural amino acid building block for solid-phase peptide synthesis (SPPS) on polyethylene glycol-grafted polystyrene resins. Loading onto a pre-swollen Rink amide AM resin (substitution 0.48 mmol·g⁻¹) is carried out in N-methyl-2-pyrrolidone using 2-(6-chloro-1H-benzotriazole-1-yl)-1,1,3,3-tetramethylaminium hexafluorophosphate (HCTU, 4 eq) and N-methylmorpholine (8 eq) as the coupling cocktail, with double 45 min coupling cycles to overcome steric hindrance from the ortho-chloro substituents. Fmoc removal employs 20% piperidine in dimethylformamide (two cycles, 5 + 15 min), monitored by UV absorbance at 304 nm. The bulky 2,5-dichlorophenyl group limits the coupling efficiency of downstream amino acids longer than 5 residues spacing is required; insertion of a glycine or β-alanine spacer immediately adjacent to this residue restores coupling yields above 98% per step as gauged by Kaiser test. Cleavage from the resin with trifluoroacetic acid/triisopropylsilane/water 95:2.5:2.5 (v/v/v) for 3 h releases the crude peptidomimetic, which is precipitated in cold diethyl ether and purified by preparative reverse-phase HPLC on a C4 250 × 21.2 mm column with a water/acetonitrile 0.1% TFA gradient system. The isolated cis-amide rotamer content at the pyrrolidine tertiary junction, measured by ¹H-¹³C HSQC NMR in DMSO-d₆, remained below 3%, confirming the backbone conformational constraint required for macrocyclic ring closure via ring-closing metathesis.

Post-synthetic modification of zirconium-based metal-organic frameworks (Zr-MOFs) of the UiO-66 topology through solvent-assisted ligand exchange (SALE) introduces enantioselective adsorption pockets for chromatographic resolution of racemic secondary alcohols and sulfoxides. A suspension of UiO-66-NH₂ microcrystals (BET surface area 1120 m²·g⁻¹) in anhydrous methanol is treated with (3R,4S)-4-(2,5-dichlorophenyl)pyrrolidine-3-carboxylic acid (3 equivalents relative to the 2-aminoterephthalate linker) at 50 °C for 36 h under static autogenous pressure. Powder X-ray diffraction confirms retention of the fcu topology with a slight unit cell expansion of 0.3%. Thermogravimetric analysis under flowing nitrogen at 10 K·min⁻¹ quantifies a linker exchange ratio of 0.32 pyrrolidine acid per Zr₆ cluster, while ¹H NMR spectroscopy of the digested framework in D₂SO₄/DMSO-d₆ corroborates chemical integrity. The resulting chiral MOF packed into stainless steel columns (100 × 4.6 mm) achieves enantioselectivity factors α = 1.45–1.72 for 1-phenylethanol and methyl p-tolyl sulfoxide under normal-phase conditions with n-heptane/ethanol 95:5 at a flow rate of 0.5 mL·min⁻¹. Operational lifetime under continuous flow exceeds 300 column volumes before measurable loss of selectivity, after which the stationary phase is regenerated by washing with 0.1 M hydrochloric acid in methanol and re-exchange with fresh ligand solution.